| 英文别名 |
N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide;Entrectinib;NMS-E628;RXDX-101;N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]benzamide;RXDX 101;Entrectinib(RXDX-101);L5ORF0AN1I;Benzamide, N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]-;Benzamide, N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-((tetrahydro-2H-pyran-4-yl)amino)-;N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide;Entrectinib [USAN:INN];Rozlytrek;YMX;Entrectinib,;N-{5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide;N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-;Entrectinib;N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide;Q25323953;N-(5-((3,5-Difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((oxan-4-yl)amino)benzamide;D10926;NCGC00484067-03;Entrectinib (RXDX-101);RG6268;Entrectinib; NMS-E628;EX-A2261;EN300-7376549;Rozlytrek (TN);C31H34F2N6O2;SB17194;CHEBI:195558;GTPL8290;L01XE56;BRD-K39009484-001-01-4;AS-75092;HAYYBYPASCDWEQ-UHFFFAOYSA-N;NMS-E628;RXDX-101;1108743-60-7;N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide;N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide;N-[5-(3,5-Difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide;RXDX101; RXDX 101; RXDX-101; NMS E628; NMS-E628;NMS E628;N-{5-[(3,5-difluorophenyl)methyl]-3H-indazol-3-ylidene}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide;AC-31286;NSC774769;RG 6268;Kinome_2659;ENTRECTINIB [WHO-DD];ENTRECTINIB [JAN];SCHEMBL3512601;CHEMBL1983268;AKOS030632786;Entrectinib, 95%;ENTRECTINIB [USAN];CCG-270048;ENTRECTINIB [MI];NMS-E 628;entrectinibum;NSC-774769;ENTRECTINIB [ORANGE BOOK];BCP16174;HY-12678;N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydropyran-4-ylamino)benzamide;Entrectinib (RXDX-101)?;NCGC00484067-01;NSC800095;N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide;N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide;NS00072566;UNII-L5ORF0AN1I;NCGC00484067-02;s7998;Entrectinib [INN];RXDX101;HMS3886H21;MFCD28129099;RXDX-101 , NMS-E628;DTXSID101026450;RG-6268;N-[5-[[3,5-bis(fluoranyl)phenyl]methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide;DB11986;DA-47850;NSC-800095;Entrectinib (JAN/USAN/INN) |